PL3041576T3 - Sposoby wykrywania choroby nerek - Google Patents

Sposoby wykrywania choroby nerek

Info

Publication number: PL3041576T3
Authority: PL; Poland
Prior art keywords: methods; renal disease; detecting renal; detecting; disease
Prior art date: 2013-09-05

Application number

PL14842603T

Other languages

English (en)

Inventor

Mahalakshmi Yerramilli

Murthy V.S.N. Yerramilli

Original Assignee

Idexx Laboratories, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-09-05

Filing date

2014-09-05

Publication date

2019-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52628954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3041576(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-09-05 Application filed by Idexx Laboratories, Inc. filed Critical Idexx Laboratories, Inc.

2019-12-31 Publication of PL3041576T3 publication Critical patent/PL3041576T3/pl

Links

208000017169 kidney disease Diseases 0.000 title 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
General Health & Medical Sciences (AREA)
Pathology (AREA)
Medicinal Chemistry (AREA)
Cell Biology (AREA)
General Physics & Mathematics (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Biophysics (AREA)
Bioinformatics & Computational Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medical Informatics (AREA)
Primary Health Care (AREA)
Epidemiology (AREA)
Databases & Information Systems (AREA)
Data Mining & Analysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Investigating Or Analysing Biological Materials (AREA)

PL14842603T 2013-09-05 2014-09-05 Sposoby wykrywania choroby nerek PL3041576T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201361874011P	2013-09-05	2013-09-05
PCT/US2014/054278 WO2015035155A1 (en)	2013-09-05	2014-09-05	Methods for detecting renal disease
EP14842603.4A EP3041576B1 (en)	2013-09-05	2014-09-05	Methods for detecting renal disease

Publications (1)

Publication Number	Publication Date
PL3041576T3 true PL3041576T3 (pl)	2019-12-31

Family

ID=52628954

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL14842603T PL3041576T3 (pl)	2013-09-05	2014-09-05	Sposoby wykrywania choroby nerek

Country Status (21)

Country	Link
US (3)	US11035861B2 (pl)
EP (3)	EP3480600B1 (pl)
JP (4)	JP6657096B2 (pl)
KR (2)	KR102273028B1 (pl)
CN (1)	CN105705202B (pl)
AU (2)	AU2014315063B2 (pl)
CA (2)	CA2923140C (pl)
CY (1)	CY1123179T1 (pl)
DK (1)	DK3041576T3 (pl)
ES (2)	ES2746008T3 (pl)
HR (1)	HRP20191569T1 (pl)
HU (1)	HUE045723T2 (pl)
LT (1)	LT3041576T (pl)
MX (2)	MX383274B (pl)
NZ (1)	NZ717554A (pl)
PL (1)	PL3041576T3 (pl)
PT (1)	PT3041576T (pl)
RS (1)	RS59287B1 (pl)
SI (1)	SI3041576T1 (pl)
SM (1)	SMT201900526T1 (pl)
WO (1)	WO2015035155A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL3041576T3 (pl)	2013-09-05	2019-12-31	Idexx Laboratories, Inc.	Sposoby wykrywania choroby nerek
FI3259593T3 (fi)	2015-02-20	2023-01-13		Homogeeninen immunomääritys, jossa on taustasignaalikompensointi
PL3289355T3 (pl) *	2015-04-30	2025-11-24	Idexx Laboratories, Inc.	Sposoby wykrywania chorób nerek
JP7344127B2 (ja)	2017-05-31	2023-09-13	マースインコーポレーテッド	慢性腎臓病の診断及び治療方法
AU2018313853A1 (en)	2017-08-08	2020-01-02	Fresenius Medical Care Holdings, Inc.	Systems and methods for treating and estimating progression of chronic kidney disease
CN111246918B (zh) *	2017-10-19	2024-06-14	艾德克斯实验室公司	对称二甲基精氨酸的检测
JP6868878B2 (ja) *	2018-10-17	2021-05-12	Kagami株式会社	糸球体濾過能力の決定方法
CN109545377B (zh) *	2018-10-22	2021-11-23	中南大学湘雅三医院	获取肾小球滤过率的模型的建立方法
US10745492B1 (en)	2019-04-03	2020-08-18	Ark Diagnostics, Inc.	Antibodies to symmetrically dimethylated arginine analytes and use thereof
CA3152793A1 (en)	2019-09-05	2021-03-11	The Regents Of The University Of California	Noninvasive method to quantify kidney function and functional decline
EP4083628B1 (en) *	2019-12-27	2026-03-11	Kagami Inc.	Method and system for estimating renal function
GB202005110D0 (en) *	2020-04-07	2020-05-20	Royal Veterinary College	Diagnosis of stage b2 dmvd
JP7784798B2 (ja) *	2020-04-17	2025-12-12	株式会社藤商事	遊技機
WO2022133159A1 (en)	2020-12-17	2022-06-23	Nephrosant, Inc.	Kits for stabilization of urine samples
CN112768073B (zh) *	2021-01-15	2023-04-18	中山大学附属第三医院	一种肾小球滤过率估计模型的构建方法
AU2022426744A1 (en) *	2021-12-27	2024-05-23	Société des Produits Nestlé S.A.	Compositions and methods for diagnosing and treating chronic kidney disease
AU2023213987A1 (en)	2022-01-26	2024-09-05	Idexx Laboratories, Inc.	Methods and compositions for differentiating progressive chronic kidney disease from stable chronic kidney disease
JP2023160475A (ja) *	2022-04-22	2023-11-02	株式会社三共	遊技機
WO2024015991A2 (en) *	2022-07-15	2024-01-18	Idexx Laboratories, Inc.	Systems and methods for at-home diagnostics utilizing microneedles
KR102880012B1 (ko) *	2023-12-22	2025-11-10	주식회사 페토바이오	반려동물의 신부전 치료를 위한 임상 의사결정 지원 시스템 및 임상 의사결정 지원 방법
CN119125582A (zh) *	2024-09-20	2024-12-13	武汉虹之彩包装印刷有限公司	一种用于肌酐检测的纸基传感器及其制备方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3134787A1 (de) *	1981-09-02	1983-03-10	Boehringer Mannheim Gmbh, 6800 Mannheim	Creatinin-antikoerper
US4818703A (en)	1985-10-23	1989-04-04	Pizzolante John M	Stabilized alkaline picrate reagent for jaffe creatinine determination
EP0356160A3 (en)	1988-08-24	1991-09-11	The Board Of Trustees Of The Leland Stanford Junior University	Capillary device
US5726010A (en)	1991-07-31	1998-03-10	Idexx Laboratories, Inc.	Reversible flow chromatographic binding assay
US6455288B1 (en)	1993-04-08	2002-09-24	Dade Behring Marburg Gmbh	Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US5804452A (en) *	1995-04-27	1998-09-08	Quidel Corporation	One step urine creatinine assays
WO1998049199A1 (en)	1997-05-01	1998-11-05	Panorama Research, Inc.	Cardiovascular disease risk assessment
US6736957B1 (en)	1997-10-16	2004-05-18	Abbott Laboratories	Biosensor electrode mediators for regeneration of cofactors and process for using
US6358699B1 (en)	1999-02-05	2002-03-19	Cooke Pharma	Assay for asymmetrical NG, NG dimethyl-l-arginine
US6699673B2 (en)	1999-12-22	2004-03-02	The Research Foundation Of State University Of New York	Protein methylarginine-specific antibodies
WO2002004465A1 (en)	2000-07-06	2002-01-17	Fal Diagnostics	Methods and kits for the detection of arginine compounds
AU2001293699A1 (en) *	2000-07-12	2002-01-21	Werner Naser	Direct assessment of analyte to reference molecule ratios
DE10040904A1 (de)	2000-08-18	2002-02-28	Boeger Rainer H	Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
US7241856B2 (en)	2003-06-02	2007-07-10	Pentron Clinical Technologies Llc	Dental resins, dental composite materials, and method of manufacture thereof
JP4214271B2 (ja)	2002-10-15	2009-01-28	アークレイ株式会社	クレアチニン測定用試験片
US7501053B2 (en)	2002-10-23	2009-03-10	Abbott Laboratories	Biosensor having improved hematocrit and oxygen biases
WO2004046314A2 (en)	2002-11-15	2004-06-03	The Board Of Trustees Of The Leland Stanford Junior University	Methods for detecting asymmetric dimethylarginine in a biological sample
US20050148029A1 (en) *	2003-09-29	2005-07-07	Biosite, Inc.	Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
DE602004020360D1 (de)	2004-11-04	2009-05-14	Germediq Forsch & Entw Ges Mbh	Methode zur Bestimmung von Arginin, methylierten Argininen und deren Derivate
US8698817B2 (en)	2004-11-15	2014-04-15	Nvidia Corporation	Video processor having scalar and vector components
WO2006078813A2 (en)	2005-01-21	2006-07-27	Biosite Incorporated	Arginine analogs, and methods for their synthesis and use
JP2007176872A (ja)	2005-12-28	2007-07-12	Sentan Seimei Kagaku Kenkyusho:Kk	アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法
FR2919063B1 (fr) *	2007-07-19	2009-10-02	Biomerieux Sa	Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
WO2009071904A1 (en)	2007-12-05	2009-06-11	King's College London	Methods and compositions
HUE051130T2 (hu) *	2008-08-07	2021-03-01	Idexx Lab Inc	Eljárások szimmetrikus dimetilarginin kimutatására
BRPI0924639B1 (pt)	2009-06-02	2021-12-07	Biocrates Life Sciences Ag	Novos biomarcadores para avaliação de doenças renais
CN101587118B (zh) *	2009-07-03	2012-09-12	长春迪瑞医疗科技股份有限公司	肌酐尿液分析试纸及制备方法
CN101598727B (zh) *	2009-07-09	2012-10-10	上海科华生物工程股份有限公司	定量测定人体血液尿素含量的干化学试纸
US9285246B2 (en) *	2010-02-12	2016-03-15	Intuitive Surgical Operations, Inc.	Method and system for absolute three-dimensional measurements using a twist-insensitive shape sensor
CN101865911A (zh) *	2010-03-16	2010-10-20	苏州市玮琪生物科技有限公司	一种尿肌酐定量检测卡
DE102011055265A1 (de)	2010-11-17	2012-05-24	Karl-Heinz Kellner	Automatenfähiger Immunoassay für biogene Amine
JP2012112785A (ja)	2010-11-24	2012-06-14	Tohoku Univ	透析膜の評価方法
JP5925026B2 (ja) *	2011-04-28	2016-05-25	アークレイ株式会社	クレアチニン測定用乾式試験片及びクレアチニン測定法
AU2012271718A1 (en) *	2011-06-16	2014-01-09	Baylor Research Institute	Analysis of total homocysteine and methylmalonic acid in plasma by LC-MS/MS from a plasma separator device (PSD)
WO2013115283A1 (ja) *	2012-01-31	2013-08-08	味の素株式会社	早期腎症の評価方法、早期腎症評価装置、早期腎症評価方法、早期腎症評価プログラム、早期腎症評価システムおよび情報通信端末装置
US20140038203A1 (en) *	2012-07-09	2014-02-06	Musc Foundation For Research Development	Methods for detecting or predicting kidney disease
PL3041576T3 (pl)	2013-09-05	2019-12-31	Idexx Laboratories, Inc.	Sposoby wykrywania choroby nerek

2014
- 2014-09-05 PL PL14842603T patent/PL3041576T3/pl unknown
- 2014-09-05 CN CN201480060296.4A patent/CN105705202B/zh active Active
- 2014-09-05 CA CA2923140A patent/CA2923140C/en active Active
- 2014-09-05 CA CA3213810A patent/CA3213810A1/en active Pending
- 2014-09-05 LT LT14842603T patent/LT3041576T/lt unknown
- 2014-09-05 JP JP2016540417A patent/JP6657096B2/ja active Active
- 2014-09-05 SI SI201431344T patent/SI3041576T1/sl unknown
- 2014-09-05 EP EP18196516.1A patent/EP3480600B1/en active Active
- 2014-09-05 AU AU2014315063A patent/AU2014315063B2/en active Active
- 2014-09-05 RS RSP20191171 patent/RS59287B1/sr unknown
- 2014-09-05 PT PT14842603T patent/PT3041576T/pt unknown
- 2014-09-05 EP EP14842603.4A patent/EP3041576B1/en active Active
- 2014-09-05 ES ES14842603T patent/ES2746008T3/es active Active
- 2014-09-05 HU HUE14842603A patent/HUE045723T2/hu unknown
- 2014-09-05 NZ NZ717554A patent/NZ717554A/en unknown
- 2014-09-05 EP EP23207400.5A patent/EP4295907A3/en active Pending
- 2014-09-05 DK DK14842603.4T patent/DK3041576T3/da active
- 2014-09-05 WO PCT/US2014/054278 patent/WO2015035155A1/en not_active Ceased
- 2014-09-05 KR KR1020167009015A patent/KR102273028B1/ko active Active
- 2014-09-05 MX MX2016002922A patent/MX383274B/es unknown
- 2014-09-05 SM SM20190526T patent/SMT201900526T1/it unknown
- 2014-09-05 ES ES18196516T patent/ES2969979T3/es active Active
- 2014-09-05 KR KR1020217020124A patent/KR102412431B1/ko active Active
- 2014-09-05 HR HRP20191569 patent/HRP20191569T1/hr unknown
2016
- 2016-03-04 MX MX2021006716A patent/MX2021006716A/es unknown
- 2016-03-04 US US15/061,327 patent/US11035861B2/en active Active
2019
- 2019-09-12 CY CY20191100954T patent/CY1123179T1/el unknown
2020
- 2020-02-05 JP JP2020017580A patent/JP2020073927A/ja active Pending
- 2020-10-16 AU AU2020256440A patent/AU2020256440B2/en active Active
2021
- 2021-06-09 US US17/343,369 patent/US20220137059A1/en not_active Abandoned
2022
- 2022-02-02 JP JP2022014586A patent/JP2022070879A/ja active Pending
2023
- 2023-11-14 JP JP2023193309A patent/JP7894843B2/ja active Active
2025
- 2025-05-06 US US19/199,936 patent/US20250271442A1/en active Pending

Also Published As

Publication number	Publication date
EP3041576A1 (en)	2016-07-13
KR102273028B1 (ko)	2021-07-02
EP3041576A4 (en)	2017-07-26
SMT201900526T1 (it)	2019-11-13
ES2746008T3 (es)	2020-03-04
EP3480600A1 (en)	2019-05-08
CA3213810A1 (en)	2015-03-12
JP6657096B2 (ja)	2020-03-04
US20220137059A1 (en)	2022-05-05
EP3480600B1 (en)	2023-11-08
EP3480600C0 (en)	2023-11-08
US11035861B2 (en)	2021-06-15
CA2923140C (en)	2023-09-26
ES2969979T3 (es)	2024-05-23
JP2020073927A (ja)	2020-05-14
LT3041576T (lt)	2019-10-25
CN105705202B (zh)	2019-02-26
HUE045723T2 (hu)	2020-01-28
CA2923140A1 (en)	2015-03-12
EP4295907A2 (en)	2023-12-27
KR102412431B1 (ko)	2022-06-22
JP2016530532A (ja)	2016-09-29
PT3041576T (pt)	2019-09-27
WO2015035155A1 (en)	2015-03-12
MX383274B (es)	2025-03-13
AU2014315063A1 (en)	2016-03-17
BR112016004839A8 (pt)	2020-02-11
KR20160051887A (ko)	2016-05-11
EP3041576B1 (en)	2019-06-19
MX2016002922A (es)	2016-11-07
AU2020256440B2 (en)	2023-03-02
MX2021006716A (es)	2021-07-15
AU2020256440A1 (en)	2020-11-12
SI3041576T1 (sl)	2019-11-29
RS59287B1 (sr)	2019-10-31
KR20210082567A (ko)	2021-07-05
US20250271442A1 (en)	2025-08-28
JP2024020376A (ja)	2024-02-14
NZ717554A (en)	2022-04-29
JP7894843B2 (ja)	2026-07-24
EP4295907A3 (en)	2024-03-13
US20160187348A1 (en)	2016-06-30
CN105705202A (zh)	2016-06-22
JP2022070879A (ja)	2022-05-13
AU2014315063B2 (en)	2020-07-23
DK3041576T3 (da)	2019-09-09
CY1123179T1 (el)	2021-10-29
HRP20191569T1 (hr)	2019-11-29

Publication	Publication Date	Title
SMT201900526T1 (it)	2019-11-13	Metodi per rilevare una malattia renale
ZA201504861B (en)	2016-03-30	Apparatus for improved disease detection
GB2527441B (en)	2021-02-03	Analysis system
HUE049446T2 (hu)	2020-09-28	Anti-FCRH5 antitestek
GB201322583D0 (en)	2014-02-05	Antibodies
AU350549S (en)	2013-09-03	Breathalyzer
IL244043A0 (en)	2016-04-21	Antibodies
HUE056308T2 (hu)	2022-02-28	Eljárás és rendszer sík félvezetõ tárgyak ellenõrzéséhez
GB201300650D0 (en)	2013-02-27	Analysis system
GB201308658D0 (en)	2013-06-26	Antibodies
GB201315486D0 (en)	2013-10-16	Antibodies
TWM476999U (en)	2014-04-21	Detecting cassette
GB201214440D0 (en)	2012-09-26	Kidney disease biomarker
GB201317621D0 (en)	2013-11-20	Kidney disease biomarker
GB201312226D0 (en)	2013-08-21	Improved antibodies
IL240319A0 (en)	2015-09-24	Quick discovery
PL3289355T3 (pl)	2025-11-24	Sposoby wykrywania chorób nerek
GB201320692D0 (en)	2014-01-08	Solenoid-actuator-armature end-of-motion detection
GB2534747B (en)	2020-10-14	Automatic image composer
GB201317540D0 (en)	2013-11-20	Sensing
PT3051152T (pt)	2020-04-23	Estrutura de ligação para peças de madeira
GB201315249D0 (en)	2013-10-09	Sensing
GB201302179D0 (en)	2013-03-27	Seabed measurement system
GB201316131D0 (en)	2013-10-23	Biomarkers for disease stratification
GB201322848D0 (en)	2014-02-12	Offset detection